Press Releases
Press Release
o2h co-work Labs Launches the World’s First Influencer Biotech Bootcamp...
Cambridge, UK, 24 Sept 2021: o2h co-work labs, a business unit of o2h Group, are absolutely delighted to launch the first ever influencer biotech bootcamp covering representatives from the quintet inf...
Press Release
o2h Technology appoints serial entrepreneur Fiona Nielsen as Chief Operations Officer
Cambridge, UK, July 1 2021: o2h technology, the software services business unit of the o2h Group, today announced it has appointed Fiona Nielsen as Chief Operations Officer, in line with recent busine...
Press Release
University of Sussex and o2h Ventures Announce Creation and Investment in Stingray Bio, a Company for New Oncology Drugs Targeting the LMTK3 Kinase Pathway
April 2021, Cambridge, UK – o2h Ventures, a UK based fund manager through investment in its SEIS and EIS human health funds is excited to announce an investment into Stingray Bio Ltd, a new spin out f...
Press Release
Nilesh Dagia, COO, o2h discovery, wins the International Institute for Sustainable Labs (I2SL) Go Beyond Award for his commitment to designing energy efficient labs in India
Colorado, USA, November 13 2019: We are absolutely delighted to announce that Nilesh Dagia, COO, o2h discovery, has won the Go Beyond Award in the Individual category at the 2019 I2SL Annual Conferenc...
Press Release
Cedilla Therapeutics and o2h Discovery Announces Multi FTE Collaboration with Cedilla Therapeutics, a Third Rock backed biotech company
Cambridge, UK/MA, September 11 2019: Cedilla Therapeutics and o2h Discovery are pleased to announce multi FTE expansion to their synthetic chemistry collaboration with Cedilla Therapeutics, a Third Ro...
Press Release
o2h Ventures Makes an Investment in Small Pharma
- Funding to enable further investigate an oral antidepressant based on a metabolite of ketamine and a 5HT2A agonist for treatment resistant depression. - Identify collaborative opportunities with Pha...
Press Release
Sunil Shah, o2h Ventures wins Angel Investor of the Year
Cambridge, UK, 4th July 2019. We are delighted to announce Sunil Shah, CEO, o2h Ventures, has won the prestigious UKBAA Angel Investor of the Year Award for his active participation in backing high gr...
Press Release
Oxford Drug Design receives over £8m in grant and equity investment
Oxford Drug Design (ODD) wins major funding awards from CARB-X, the UK Department of Health and Social Care (DHSC) and an equity investment led by o2h Ventures totaling over £8m to develop new antibio...
Press Release
The o2h Therapeutics Fund makes its first investment
Cambridge, UK, 18 March 2019. The o2h Therapeutics Fund & AI (“The Fund”), an early stage S/EIS fund investing in biotech therapeutic and related AI opportunities, has made its first investment, backi...
Press Release
o2h Ventures launches new SEIS/EIS fund
Cambridge, UK, 18 February, 2019. o2h Ventures Limited (“o2h Ventures”), an investment firm which specialises in backing biotech companies, has launched a new SEIS/EIS fund. The o2h Therapeutics Fund...